Brief: Schott Pharma Q3 Revenues Up 21% Y-o-y

SCHOTT Pharma AG & Co KgaA

29/08/2024 11:03

Aug 29 (Reuters) - SCHOTT PHARMA AG & CO KGAA  1SXP.DE :
    * DELIVERS STRONG THIRD QUARTER RESULTS AND RAISES FY 2024
REVENUE
GUIDANCE
    * Q3 2024 REVENUES UP 21% YOY TO EUR 268M AT CONSTANT
CURRENCIES
    * STRONG Q3 2024 EBITDA MARGIN OF 28.2% AT CONSTANT

Source text for Eikon:  ID:nEQ9NZn2na 
Further company coverage:  1SXP.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))